RAYMOND JAMES & ASSOCIATES - KYMERA THERAPEUTICS INC ownership

KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 128 filers reported holding KYMERA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of KYMERA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$365,521
-34.9%
26,297
+7.7%
0.00%
Q2 2023$561,153
-17.4%
24,409
+6.4%
0.00%
-100.0%
Q1 2023$679,438
+62.2%
22,931
+36.6%
0.00%
Q4 2022$418,854
+17.0%
16,781
+1.9%
0.00%
Q3 2022$358,00016,4640.00%
Other shareholders
KYMERA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Atlas Venture Life Science Advisors, LLC 5,984,736$149,379,01117.99%
Aquilo Capital Management, LLC 629,411$15,710,0995.90%
BVF INC/IL 4,692,604$117,127,3964.94%
Artal Group S.A. 2,000,000$49,9202.79%
Redmile Group, LLC 2,673,837$66,738,9722.73%
Avoro Capital Advisors LLC 3,850,000$96,096,0001.44%
Deer Management Co. LLC 615,895$15,372,7391.42%
AtonRa Partners 27,125$677,0400.86%
Rock Springs Capital Management LP 1,227,779$30,645,3640.74%
EcoR1 Capital, LLC 796,093$19,870,4810.60%
View complete list of KYMERA THERAPEUTICS INC shareholders